Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. part 3
- 31 January 2011
- journal article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 46 (1), 142-149
- https://doi.org/10.1016/j.ejmech.2010.10.026
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Serotonin Receptor and Transporter Ligands - Current StatusCurrent Medicinal Chemistry, 2001
- Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635Archives of General Psychiatry, 2000
- A review of central 5-HT receptors and their functionNeuropharmacology, 1999
- Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT1AReceptorsJournal of Neuroscience, 1998
- Increase in Serotonin-1A Autoreceptors in the Midbrain of Suicide Victims with Major Depression—Postmortem Evidence for Decreased Serotonin ActivityJournal of Neuroscience, 1998
- Effect of a selective 5‐HT reuptake inhibitor in combination with 5‐HT1A and 5‐HT1B receptor antagonists on extracellular 5‐HT in rat frontal cortex in vivoBritish Journal of Pharmacology, 1997
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake InhibitorsArchives of General Psychiatry, 1994
- Serotonin 5‐HT1A Autoreceptor Blockade Potentiates the Ability of the 5‐HT Reuptake Inhibitor Citalopram to Increase Nerve Terminal Output of 5‐HT In Vivo: A Microdialysis StudyJournal of Neurochemistry, 1993
- Brain 5-HT1 binding sites in depressed suicidesPsychopharmacology, 1990